Skip to content

Watching Live VIA/VILI Examinations on a Digital Screen May Reduce Patients' Anxiety

Watching Live VIA/VILI Examinations on a Digital Screen May Reduce Patients' Anxiety: a Randomized Trial of an Educational Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02945111
Enrollment
122
Registered
2016-10-26
Start date
2016-09-30
Completion date
2016-10-31
Last updated
2016-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Cervical Cancer

Brief summary

The purpose of this study is to assess whether the degree of anxiety experienced by women undergoing visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) can be reduced by watching the procedure in real-time on a digital screen.

Detailed description

The study took place in the District of Dschang, Cameroon. Women aged between 30 and 49 years, addressed to undergo a pelvic examination with VIA and VILI, were invited to participate. Throughout the examination, one part of the women underwent the routine VIA/VILI, with no visual support (control group), whereas the other part of patients were shown the pictures of the cervix in real-time on a digital screen (study group). At the end of the procedure, all women had the possibility to see the pictures retrospectively. Randomization determined the women's distribution between the two groups. Their anxiety level was measured by asking them to complete the Spielberg's State Anxiety Inventory (STAI) both prior to and immediately after the procedure.

Interventions

BEHAVIORALReal-time view
BEHAVIORALNo visual support

Sponsors

Prof. Patrick Petignat
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Women participating in a cervical cancer screening campaign organized by the District hospital of Dschang * Women understanding the study procedure and accepting voluntarily to participate by signing an informed consent form (ICF).

Exclusion criteria

* Women not able to comply with the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Anxiety levelWithin thirty minutes of the VIA/VILI examinationAnxiety level will be assessed through the STAI questionnaire

Countries

Cameroon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026